|
⚲
|
| Keyboard |
| Lindmark Bertil
✚
|
|
|---|---|
| CIK # | 0001825778 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001825778] | |
| 4 | [0001825778] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Damora Therapeutics Inc | |
| Lindmark Bertil |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2023-01-04 | Grant | 115,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2022-03-22 | Buy | 14,604 | $2.16 | 31,545 |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2022-01-04 | Grant | 118,750 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2021-06-28 | Buy | 2,000 | $5.26 | 10,520 |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-01-05 | Grant | 95,000 | $0.00 |